Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
MENINGO-COCCAL POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE bulk supplier for pharma manufacturers

Meningo-Coccal Polysaccharide Diphtheria Toxoid Conjugate 4 mcg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 4 mcg

Reference Brands: Menactra (USA)

Category: Vaccines

Meningococcal polysaccharide diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria. The vaccine works by causing your body to produce its own protection (antibodies) against the bacteria.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Meningo-Coccal Polysaccharide Diphtheria Toxoid Conjugate? List it or send an offer →

Product Description:

Meningococcal infection can cause life-threatening illnesses, such as meningococcal meningitis, which affects the brain, and meningococcemia, which affects the blood. Some persons with meningococcal meningitis and/or meningococcemia may die. The rate of these diseases peak in adolescence and early adulthood and are more likely to occur in persons with certain diseases or conditions that make them more susceptible to a meningococcal infection or more likely to develop serious problems from a meningococcal infection.

Meningo-Coccal Polysaccharide Diphtheria Toxoid Conjugate — third party manufacturing & bulk supply

Meningo-Coccal Polysaccharide Diphtheria Toxoid Conjugate 4 mcg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Meningo-Coccal Polysaccharide Diphtheria Toxoid Conjugate is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Meningo-Coccal Polysaccharide Diphtheria Toxoid Conjugate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Meningo-Coccal Polysaccharide Diphtheria... →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine is used to prevent meningococcal disease caused by Neisseria meningitidis. It helps protect against serious infections such as meningitis and bloodstream infections that can lead to severe complications or death.

This vaccine is made from purified capsular polysaccharides of Neisseria meningitidis bacteria that are chemically linked to diphtheria toxoid protein. The conjugation improves the immune response, particularly in children and adolescents.

Common trade names include Menactra, Menveo, and Nimenrix.

This vaccine is manufactured by pharmaceutical companies such as Sanofi Pasteur, GlaxoSmithKline (GSK), and Pfizer.

The generic name is meningococcal polysaccharide diphtheria toxoid conjugate vaccine.

Brand names include Menactra, Menveo, and Nimenrix.

This vaccine is manufactured in several countries including the United States, Italy, Belgium, and other regions depending on the manufacturer.Menactra

Related Products

HPV Vaccine

Strength:
20 mcg, 30 mcg, 40 mcg

Form: Injection

Reference Brands: Gardasil (USA/EU), Cervarix (EU)

View Details
Typhoid Vaccine

Strength:
0.5 mL per dose; 2.5 mL multi-dose vial

Form: Injection

Reference Brands:

View Details
Pneumococcal Vaccine

Strength:
0.5ML

Form: Injection

Reference Brands:

View Details
Purified VERO CELL Rabies Vaccine

Strength:
2.5 IU

Form: Injection

Reference Brands: Verorab (LATAM)

View Details
IPV (Inactivated Polio Vaccine)

Strength:
0.5 mL

Form: Injectable suspension (IM administration), Pre-filled syringes

Reference Brands: IPOL(US)

View Details
MMR (Measles, Mumps, Rubella) Vaccine

Strength:
ose equivalent to 10 or 20 doses per vial

Form: Pre-filled syringes. Vials (lyophilized powder for reconstitution)

Reference Brands: M-M-R II. Priorix(US)

View Details
Rotavirus Vaccine

Strength:
2 mL RotaTeq; 1 mL Rotarix

Form: Oral liquid vaccine (suspension), Powder for reconstitution

Reference Brands: RotaTeq, Rotarix (US)

View Details
PCV (Pneumococcal Conjugate Vaccine)

Strength:
0.5 mL

Form: Vial doses, Pre-filled syringes

Reference Brands: Prevnar 13(US)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us